CIBC Private Wealth Group
MDCO

CIBC Private Wealth Group’s Medicines Co MDCO Stock Holding History

CIBC Private Wealth Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-58,321
Closed -$2.92M – 942
2019
Q3 		$2.92M Buy
58,321
+42,680
+273% +$1.7M 0.01% 411
2019
Q2 		$570K Buy
15,641
+173
+1% +$5.65K ﹤0.01% 687
2019
Q1 		$432K Buy
15,468
+3,350
+28% +$79K ﹤0.01% 753
2018
Q4 		$232K Buy
+12,118
New +$282K ﹤0.01% 811
2018
Q2 		– Sell
-100
Closed -$3K – 2154
2018
Q1 		$3K Hold
100
– – ﹤0.01% 1770
2017
Q4 		$3K Buy
+100
New +$3.08K ﹤0.01% 1793
2017
Q3 		– Sell
-10,400
Closed -$395K – 947
2017
Q2 		$395K Buy
+10,400
New +$463K ﹤0.01% 557

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

CIBC Private Wealth Group's MDCO Position: Q4 2019 in Review

CIBC Private Wealth Group sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 58,321 shares — an estimated $2.92M sold.

CIBC Private Wealth Group first reported a position in MDCO in Q2 2017 and held it in 7 quarters. The position peaked at $2.92M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • CIBC Private Wealth Group reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • CIBC Private Wealth Group sold 58,321 Medicines Co shares in Q4 2019, an estimated $2.92M.
  • CIBC Private Wealth Group first reported a position in Medicines Co in Q2 2017 and held it in 7 quarters.
  • CIBC Private Wealth Group's Medicines Co position peaked at $2.92M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on CIBC Private Wealth Group's 13F filing for Q4 2019, filed 30 Jan 2020.